nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Furosemide—SLC22A5—Crohn's disease	0.0162	0.595	CrCbGaD
Indapamide—CA9—gall bladder—Crohn's disease	0.0143	0.169	CbGeAlD
Indapamide—KCNQ1—mammalian vulva—Crohn's disease	0.00663	0.0787	CbGeAlD
Indapamide—CA7—digestive system—Crohn's disease	0.00639	0.0758	CbGeAlD
Indapamide—KCNQ1—digestive system—Crohn's disease	0.00582	0.069	CbGeAlD
Indapamide—CA9—digestive system—Crohn's disease	0.00561	0.0666	CbGeAlD
Indapamide—CA2—gall bladder—Crohn's disease	0.00541	0.0642	CbGeAlD
Indapamide—Cystitis—Mesalazine—Crohn's disease	0.00508	0.00571	CcSEcCtD
Indapamide—Candida infection—Mesalazine—Crohn's disease	0.00502	0.00565	CcSEcCtD
Indapamide—Blood urea increased—Mesalazine—Crohn's disease	0.00496	0.00559	CcSEcCtD
Indapamide—Vaginal infection—Mesalazine—Crohn's disease	0.00496	0.00559	CcSEcCtD
Indapamide—Aplastic anaemia—Mesalazine—Crohn's disease	0.00494	0.00556	CcSEcCtD
Indapamide—CA2—mouth—Crohn's disease	0.00482	0.0571	CbGeAlD
Indapamide—Fracture—Prednisone—Crohn's disease	0.00479	0.00539	CcSEcCtD
Indapamide—Multiple fractures—Prednisone—Crohn's disease	0.00479	0.00539	CcSEcCtD
Indapamide—Ecchymosis—Mesalazine—Crohn's disease	0.00475	0.00535	CcSEcCtD
Indapamide—Bladder pain—Mesalazine—Crohn's disease	0.00475	0.00535	CcSEcCtD
Indapamide—Hepatic failure—Azathioprine—Crohn's disease	0.00466	0.00525	CcSEcCtD
Indapamide—Hypertonia—Mesalazine—Crohn's disease	0.00461	0.00519	CcSEcCtD
Indapamide—Optic neuritis—Prednisone—Crohn's disease	0.00452	0.00509	CcSEcCtD
Indapamide—Furosemide—ALB—Crohn's disease	0.00449	0.165	CrCbGaD
Indapamide—Ear pain—Mesalazine—Crohn's disease	0.00447	0.00503	CcSEcCtD
Indapamide—Photosensitivity—Mesalazine—Crohn's disease	0.00435	0.00489	CcSEcCtD
Indapamide—Gastroenteritis—Mesalazine—Crohn's disease	0.00431	0.00485	CcSEcCtD
Indapamide—Hepatic failure—Mesalazine—Crohn's disease	0.00425	0.00478	CcSEcCtD
Indapamide—CA5B—mammalian vulva—Crohn's disease	0.00425	0.0504	CbGeAlD
Indapamide—Malnutrition—Mercaptopurine—Crohn's disease	0.00423	0.00477	CcSEcCtD
Indapamide—CA12—digestive system—Crohn's disease	0.00415	0.0492	CbGeAlD
Indapamide—Libido decreased—Mesalazine—Crohn's disease	0.00412	0.00463	CcSEcCtD
Indapamide—Increased appetite—Mesalazine—Crohn's disease	0.00406	0.00457	CcSEcCtD
Indapamide—Atrial fibrillation—Mesalazine—Crohn's disease	0.00403	0.00453	CcSEcCtD
Indapamide—Dermatitis bullous—Mesalazine—Crohn's disease	0.00399	0.00449	CcSEcCtD
Indapamide—Myopathy—Prednisone—Crohn's disease	0.00397	0.00446	CcSEcCtD
Indapamide—Arthritis—Mesalazine—Crohn's disease	0.00393	0.00442	CcSEcCtD
Indapamide—Anaemia—Mercaptopurine—Crohn's disease	0.00391	0.0044	CcSEcCtD
Indapamide—Lethargy—Mesalazine—Crohn's disease	0.00389	0.00438	CcSEcCtD
Indapamide—Bumetanide—PTGS2—Crohn's disease	0.00382	0.14	CrCbGaD
Indapamide—Osteoarthritis—Mesalazine—Crohn's disease	0.00382	0.0043	CcSEcCtD
Indapamide—Leukopenia—Mercaptopurine—Crohn's disease	0.00379	0.00427	CcSEcCtD
Indapamide—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00379	0.00426	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00377	0.00425	CcSEcCtD
Indapamide—Migraine—Mesalazine—Crohn's disease	0.00376	0.00423	CcSEcCtD
Indapamide—Face oedema—Mesalazine—Crohn's disease	0.00368	0.00415	CcSEcCtD
Indapamide—Arthralgia—Mercaptopurine—Crohn's disease	0.0036	0.00406	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00358	0.00403	CcSEcCtD
Indapamide—Pancreatitis—Azathioprine—Crohn's disease	0.00355	0.004	CcSEcCtD
Indapamide—Liver function test abnormal—Mesalazine—Crohn's disease	0.00352	0.00397	CcSEcCtD
Indapamide—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00349	0.00392	CcSEcCtD
Indapamide—Abdominal pain upper—Mesalazine—Crohn's disease	0.00349	0.00392	CcSEcCtD
Indapamide—Oedema—Mercaptopurine—Crohn's disease	0.00346	0.00389	CcSEcCtD
Indapamide—Cramp muscle—Mesalazine—Crohn's disease	0.00344	0.00387	CcSEcCtD
Indapamide—Glycosuria—Prednisone—Crohn's disease	0.00343	0.00386	CcSEcCtD
Indapamide—Nasopharyngitis—Mesalazine—Crohn's disease	0.00341	0.00384	CcSEcCtD
Indapamide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00338	0.00381	CcSEcCtD
Indapamide—Gastritis—Mesalazine—Crohn's disease	0.00338	0.0038	CcSEcCtD
Indapamide—Skin disorder—Mercaptopurine—Crohn's disease	0.00336	0.00378	CcSEcCtD
Indapamide—KCNQ1—lymph node—Crohn's disease	0.00332	0.0394	CbGeAlD
Indapamide—Influenza—Mesalazine—Crohn's disease	0.0033	0.00371	CcSEcCtD
Indapamide—Asthma—Mesalazine—Crohn's disease	0.0033	0.00371	CcSEcCtD
Indapamide—Dysphagia—Mesalazine—Crohn's disease	0.0033	0.00371	CcSEcCtD
Indapamide—Anorexia—Mercaptopurine—Crohn's disease	0.00329	0.00371	CcSEcCtD
Indapamide—Pneumonia—Azathioprine—Crohn's disease	0.00325	0.00365	CcSEcCtD
Indapamide—Pancreatitis—Mesalazine—Crohn's disease	0.00323	0.00364	CcSEcCtD
Indapamide—Angina pectoris—Mesalazine—Crohn's disease	0.00321	0.00362	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.0032	0.0036	CcSEcCtD
Indapamide—Bronchitis—Mesalazine—Crohn's disease	0.00317	0.00357	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00315	0.00354	CcSEcCtD
Indapamide—Dysuria—Mesalazine—Crohn's disease	0.00308	0.00347	CcSEcCtD
Indapamide—Arthropathy—Prednisone—Crohn's disease	0.00306	0.00344	CcSEcCtD
Indapamide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00305	0.00344	CcSEcCtD
Indapamide—Pollakiuria—Mesalazine—Crohn's disease	0.00305	0.00343	CcSEcCtD
Indapamide—Agranulocytosis—Azathioprine—Crohn's disease	0.00301	0.00339	CcSEcCtD
Indapamide—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00301	0.00339	CcSEcCtD
Indapamide—Decreased appetite—Mercaptopurine—Crohn's disease	0.003	0.00338	CcSEcCtD
Indapamide—Weight decreased—Mesalazine—Crohn's disease	0.00298	0.00336	CcSEcCtD
Indapamide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00298	0.00336	CcSEcCtD
Indapamide—Pneumonia—Mesalazine—Crohn's disease	0.00296	0.00333	CcSEcCtD
Indapamide—Depression—Mesalazine—Crohn's disease	0.00293	0.0033	CcSEcCtD
Indapamide—Cataract—Prednisone—Crohn's disease	0.00292	0.00329	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00292	0.00328	CcSEcCtD
Indapamide—Renal failure—Mesalazine—Crohn's disease	0.00289	0.00325	CcSEcCtD
Indapamide—Stomatitis—Mesalazine—Crohn's disease	0.00287	0.00323	CcSEcCtD
Indapamide—Jaundice—Mesalazine—Crohn's disease	0.00287	0.00323	CcSEcCtD
Indapamide—Conjunctivitis—Mesalazine—Crohn's disease	0.00286	0.00322	CcSEcCtD
Indapamide—Urinary tract infection—Mesalazine—Crohn's disease	0.00286	0.00322	CcSEcCtD
Indapamide—Vasculitis—Prednisone—Crohn's disease	0.00285	0.00321	CcSEcCtD
Indapamide—Sweating—Mesalazine—Crohn's disease	0.00282	0.00317	CcSEcCtD
Indapamide—CA2—epithelium—Crohn's disease	0.0028	0.0332	CbGeAlD
Indapamide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00278	0.00313	CcSEcCtD
Indapamide—Sinusitis—Mesalazine—Crohn's disease	0.00276	0.00311	CcSEcCtD
Indapamide—Agranulocytosis—Mesalazine—Crohn's disease	0.00274	0.00309	CcSEcCtD
Indapamide—Erythema multiforme—Azathioprine—Crohn's disease	0.00274	0.00308	CcSEcCtD
Indapamide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00273	0.00307	CcSEcCtD
Indapamide—Oxcarbazepine—ALB—Crohn's disease	0.00271	0.0994	CrCbGaD
Indapamide—CA2—smooth muscle tissue—Crohn's disease	0.0027	0.032	CbGeAlD
Indapamide—CA2—skin of body—Crohn's disease	0.00266	0.0316	CbGeAlD
Indapamide—Rhinitis—Mesalazine—Crohn's disease	0.00265	0.00298	CcSEcCtD
Indapamide—Hepatitis—Mesalazine—Crohn's disease	0.00264	0.00297	CcSEcCtD
Indapamide—Pharyngitis—Mesalazine—Crohn's disease	0.00262	0.00295	CcSEcCtD
Indapamide—Urinary tract disorder—Mesalazine—Crohn's disease	0.00261	0.00293	CcSEcCtD
Indapamide—Oedema peripheral—Mesalazine—Crohn's disease	0.0026	0.00293	CcSEcCtD
Indapamide—Arrhythmia—Azathioprine—Crohn's disease	0.00259	0.00291	CcSEcCtD
Indapamide—Urethral disorder—Mesalazine—Crohn's disease	0.00259	0.00291	CcSEcCtD
Indapamide—CA4—digestive system—Crohn's disease	0.00257	0.0305	CbGeAlD
Indapamide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00255	0.00287	CcSEcCtD
Indapamide—Oesophagitis—Prednisone—Crohn's disease	0.00254	0.00286	CcSEcCtD
Indapamide—Ecchymosis—Prednisone—Crohn's disease	0.00251	0.00283	CcSEcCtD
Indapamide—Erythema multiforme—Mesalazine—Crohn's disease	0.0025	0.00281	CcSEcCtD
Indapamide—Tinnitus—Mesalazine—Crohn's disease	0.00246	0.00277	CcSEcCtD
Indapamide—Cardiac disorder—Mesalazine—Crohn's disease	0.00245	0.00276	CcSEcCtD
Indapamide—CA2—mammalian vulva—Crohn's disease	0.00243	0.0288	CbGeAlD
Indapamide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00236	0.00266	CcSEcCtD
Indapamide—Ill-defined disorder—Azathioprine—Crohn's disease	0.00234	0.00263	CcSEcCtD
Indapamide—Anaemia—Azathioprine—Crohn's disease	0.00233	0.00262	CcSEcCtD
Indapamide—Diabetes mellitus—Prednisone—Crohn's disease	0.00232	0.00261	CcSEcCtD
Indapamide—Erythema—Mesalazine—Crohn's disease	0.0023	0.00259	CcSEcCtD
Indapamide—Malaise—Azathioprine—Crohn's disease	0.00228	0.00256	CcSEcCtD
Indapamide—Flatulence—Mesalazine—Crohn's disease	0.00226	0.00255	CcSEcCtD
Indapamide—Leukopenia—Azathioprine—Crohn's disease	0.00226	0.00254	CcSEcCtD
Indapamide—Vascular purpura—Prednisone—Crohn's disease	0.00226	0.00254	CcSEcCtD
Indapamide—Tension—Mesalazine—Crohn's disease	0.00226	0.00254	CcSEcCtD
Indapamide—Dysgeusia—Mesalazine—Crohn's disease	0.00225	0.00253	CcSEcCtD
Indapamide—Nervousness—Mesalazine—Crohn's disease	0.00223	0.00251	CcSEcCtD
Indapamide—Back pain—Mesalazine—Crohn's disease	0.00222	0.0025	CcSEcCtD
Indapamide—Muscle spasms—Mesalazine—Crohn's disease	0.00221	0.00249	CcSEcCtD
Indapamide—Vomiting—Mercaptopurine—Crohn's disease	0.0022	0.00247	CcSEcCtD
Indapamide—Rash—Mercaptopurine—Crohn's disease	0.00218	0.00245	CcSEcCtD
Indapamide—Dermatitis—Mercaptopurine—Crohn's disease	0.00218	0.00245	CcSEcCtD
Indapamide—Vision blurred—Mesalazine—Crohn's disease	0.00217	0.00244	CcSEcCtD
Indapamide—CA2—lymphoid tissue—Crohn's disease	0.00216	0.0256	CbGeAlD
Indapamide—Amnesia—Prednisone—Crohn's disease	0.00215	0.00242	CcSEcCtD
Indapamide—Increased appetite—Prednisone—Crohn's disease	0.00215	0.00242	CcSEcCtD
Indapamide—Arthralgia—Azathioprine—Crohn's disease	0.00215	0.00242	CcSEcCtD
Indapamide—Myalgia—Azathioprine—Crohn's disease	0.00215	0.00242	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00213	0.0024	CcSEcCtD
Indapamide—Ill-defined disorder—Mesalazine—Crohn's disease	0.00213	0.0024	CcSEcCtD
Indapamide—CA2—digestive system—Crohn's disease	0.00213	0.0253	CbGeAlD
Indapamide—CA5B—lymph node—Crohn's disease	0.00213	0.0252	CbGeAlD
Indapamide—Anaemia—Mesalazine—Crohn's disease	0.00212	0.00239	CcSEcCtD
Indapamide—Discomfort—Azathioprine—Crohn's disease	0.00212	0.00239	CcSEcCtD
Indapamide—Angioedema—Mesalazine—Crohn's disease	0.0021	0.00236	CcSEcCtD
Indapamide—Purpura—Prednisone—Crohn's disease	0.00209	0.00236	CcSEcCtD
Indapamide—Malaise—Mesalazine—Crohn's disease	0.00207	0.00233	CcSEcCtD
Indapamide—Vertigo—Mesalazine—Crohn's disease	0.00206	0.00232	CcSEcCtD
Indapamide—Syncope—Mesalazine—Crohn's disease	0.00206	0.00232	CcSEcCtD
Indapamide—Lethargy—Prednisone—Crohn's disease	0.00206	0.00232	CcSEcCtD
Indapamide—Leukopenia—Mesalazine—Crohn's disease	0.00206	0.00232	CcSEcCtD
Indapamide—Nausea—Mercaptopurine—Crohn's disease	0.00205	0.00231	CcSEcCtD
Indapamide—Infection—Azathioprine—Crohn's disease	0.00205	0.0023	CcSEcCtD
Indapamide—Palpitations—Mesalazine—Crohn's disease	0.00203	0.00229	CcSEcCtD
Indapamide—Loss of consciousness—Mesalazine—Crohn's disease	0.00202	0.00227	CcSEcCtD
Indapamide—Osteoarthritis—Prednisone—Crohn's disease	0.00202	0.00227	CcSEcCtD
Indapamide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00202	0.00227	CcSEcCtD
Indapamide—Cough—Mesalazine—Crohn's disease	0.00201	0.00226	CcSEcCtD
Indapamide—Skin disorder—Azathioprine—Crohn's disease	0.002	0.00225	CcSEcCtD
Indapamide—Arthralgia—Mesalazine—Crohn's disease	0.00196	0.0022	CcSEcCtD
Indapamide—Chest pain—Mesalazine—Crohn's disease	0.00196	0.0022	CcSEcCtD
Indapamide—Myalgia—Mesalazine—Crohn's disease	0.00196	0.0022	CcSEcCtD
Indapamide—Anxiety—Mesalazine—Crohn's disease	0.00195	0.00219	CcSEcCtD
Indapamide—Face oedema—Prednisone—Crohn's disease	0.00195	0.00219	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00194	0.00219	CcSEcCtD
Indapamide—Discomfort—Mesalazine—Crohn's disease	0.00193	0.00218	CcSEcCtD
Indapamide—Irritability—Prednisone—Crohn's disease	0.00193	0.00217	CcSEcCtD
Indapamide—Hypotension—Azathioprine—Crohn's disease	0.00192	0.00217	CcSEcCtD
Indapamide—Dry mouth—Mesalazine—Crohn's disease	0.00191	0.00215	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00188	0.00211	CcSEcCtD
Indapamide—Anaphylactic shock—Mesalazine—Crohn's disease	0.00188	0.00211	CcSEcCtD
Indapamide—Oedema—Mesalazine—Crohn's disease	0.00188	0.00211	CcSEcCtD
Indapamide—Infection—Mesalazine—Crohn's disease	0.00186	0.0021	CcSEcCtD
Indapamide—Shock—Mesalazine—Crohn's disease	0.00185	0.00208	CcSEcCtD
Indapamide—Nervous system disorder—Mesalazine—Crohn's disease	0.00184	0.00207	CcSEcCtD
Indapamide—Hypokalaemia—Prednisone—Crohn's disease	0.00184	0.00207	CcSEcCtD
Indapamide—Thrombocytopenia—Mesalazine—Crohn's disease	0.00184	0.00207	CcSEcCtD
Indapamide—Tachycardia—Mesalazine—Crohn's disease	0.00183	0.00206	CcSEcCtD
Indapamide—Skin disorder—Mesalazine—Crohn's disease	0.00182	0.00205	CcSEcCtD
Indapamide—Hyperhidrosis—Mesalazine—Crohn's disease	0.00181	0.00204	CcSEcCtD
Indapamide—Anorexia—Mesalazine—Crohn's disease	0.00179	0.00201	CcSEcCtD
Indapamide—Muscular weakness—Prednisone—Crohn's disease	0.00178	0.002	CcSEcCtD
Indapamide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00178	0.002	CcSEcCtD
Indapamide—Hypotension—Mesalazine—Crohn's disease	0.00175	0.00197	CcSEcCtD
Indapamide—Pancreatitis—Prednisone—Crohn's disease	0.00171	0.00193	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00171	0.00192	CcSEcCtD
Indapamide—Feeling abnormal—Azathioprine—Crohn's disease	0.0017	0.00191	CcSEcCtD
Indapamide—Insomnia—Mesalazine—Crohn's disease	0.0017	0.00191	CcSEcCtD
Indapamide—Paraesthesia—Mesalazine—Crohn's disease	0.00168	0.0019	CcSEcCtD
Indapamide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00168	0.0019	CcSEcCtD
Indapamide—Dyspnoea—Mesalazine—Crohn's disease	0.00167	0.00188	CcSEcCtD
Indapamide—Somnolence—Mesalazine—Crohn's disease	0.00167	0.00188	CcSEcCtD
Indapamide—Dyspepsia—Mesalazine—Crohn's disease	0.00165	0.00186	CcSEcCtD
Indapamide—Decreased appetite—Mesalazine—Crohn's disease	0.00163	0.00184	CcSEcCtD
Indapamide—Abdominal pain—Azathioprine—Crohn's disease	0.00163	0.00183	CcSEcCtD
Indapamide—Body temperature increased—Azathioprine—Crohn's disease	0.00163	0.00183	CcSEcCtD
Indapamide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00162	0.00182	CcSEcCtD
Indapamide—Fatigue—Mesalazine—Crohn's disease	0.00162	0.00182	CcSEcCtD
Indapamide—Erectile dysfunction—Prednisone—Crohn's disease	0.00161	0.00181	CcSEcCtD
Indapamide—Constipation—Mesalazine—Crohn's disease	0.0016	0.00181	CcSEcCtD
Indapamide—Pain—Mesalazine—Crohn's disease	0.0016	0.00181	CcSEcCtD
Indapamide—Weight decreased—Prednisone—Crohn's disease	0.00158	0.00178	CcSEcCtD
Indapamide—Hyperglycaemia—Prednisone—Crohn's disease	0.00157	0.00177	CcSEcCtD
Indapamide—Depression—Prednisone—Crohn's disease	0.00155	0.00175	CcSEcCtD
Indapamide—Feeling abnormal—Mesalazine—Crohn's disease	0.00155	0.00174	CcSEcCtD
Indapamide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00153	0.00173	CcSEcCtD
Indapamide—Hypersensitivity—Azathioprine—Crohn's disease	0.00152	0.00171	CcSEcCtD
Indapamide—Urticaria—Mesalazine—Crohn's disease	0.00149	0.00168	CcSEcCtD
Indapamide—Body temperature increased—Mesalazine—Crohn's disease	0.00148	0.00167	CcSEcCtD
Indapamide—Abdominal pain—Mesalazine—Crohn's disease	0.00148	0.00167	CcSEcCtD
Indapamide—CA4—lymph node—Crohn's disease	0.00147	0.0174	CbGeAlD
Indapamide—Diarrhoea—Azathioprine—Crohn's disease	0.00141	0.00159	CcSEcCtD
Indapamide—Hypersensitivity—Mesalazine—Crohn's disease	0.00138	0.00156	CcSEcCtD
Indapamide—CYP3A4—digestive system—Crohn's disease	0.00137	0.0163	CbGeAlD
Indapamide—Dizziness—Azathioprine—Crohn's disease	0.00136	0.00153	CcSEcCtD
Indapamide—Asthenia—Mesalazine—Crohn's disease	0.00135	0.00151	CcSEcCtD
Indapamide—Pruritus—Mesalazine—Crohn's disease	0.00133	0.00149	CcSEcCtD
Indapamide—Vomiting—Azathioprine—Crohn's disease	0.00131	0.00147	CcSEcCtD
Indapamide—Rash—Azathioprine—Crohn's disease	0.0013	0.00146	CcSEcCtD
Indapamide—Dermatitis—Azathioprine—Crohn's disease	0.0013	0.00146	CcSEcCtD
Indapamide—Flushing—Prednisone—Crohn's disease	0.0013	0.00146	CcSEcCtD
Indapamide—Headache—Azathioprine—Crohn's disease	0.00129	0.00145	CcSEcCtD
Indapamide—Diarrhoea—Mesalazine—Crohn's disease	0.00128	0.00144	CcSEcCtD
Indapamide—Arrhythmia—Prednisone—Crohn's disease	0.00125	0.0014	CcSEcCtD
Indapamide—Dizziness—Mesalazine—Crohn's disease	0.00124	0.0014	CcSEcCtD
Indapamide—Nausea—Azathioprine—Crohn's disease	0.00122	0.00138	CcSEcCtD
Indapamide—CA2—lymph node—Crohn's disease	0.00122	0.0144	CbGeAlD
Indapamide—Erythema—Prednisone—Crohn's disease	0.00122	0.00137	CcSEcCtD
Indapamide—Malnutrition—Prednisone—Crohn's disease	0.00122	0.00137	CcSEcCtD
Indapamide—Vomiting—Mesalazine—Crohn's disease	0.00119	0.00134	CcSEcCtD
Indapamide—Rash—Mesalazine—Crohn's disease	0.00118	0.00133	CcSEcCtD
Indapamide—Dermatitis—Mesalazine—Crohn's disease	0.00118	0.00133	CcSEcCtD
Indapamide—Headache—Mesalazine—Crohn's disease	0.00117	0.00132	CcSEcCtD
Indapamide—Vision blurred—Prednisone—Crohn's disease	0.00115	0.00129	CcSEcCtD
Indapamide—Ill-defined disorder—Prednisone—Crohn's disease	0.00113	0.00127	CcSEcCtD
Indapamide—Anaemia—Prednisone—Crohn's disease	0.00112	0.00126	CcSEcCtD
Indapamide—Agitation—Prednisone—Crohn's disease	0.00112	0.00126	CcSEcCtD
Indapamide—Nausea—Mesalazine—Crohn's disease	0.00111	0.00125	CcSEcCtD
Indapamide—Angioedema—Prednisone—Crohn's disease	0.00111	0.00125	CcSEcCtD
Indapamide—Malaise—Prednisone—Crohn's disease	0.0011	0.00123	CcSEcCtD
Indapamide—Vertigo—Prednisone—Crohn's disease	0.00109	0.00123	CcSEcCtD
Indapamide—Syncope—Prednisone—Crohn's disease	0.00109	0.00123	CcSEcCtD
Indapamide—Loss of consciousness—Prednisone—Crohn's disease	0.00107	0.0012	CcSEcCtD
Indapamide—Myalgia—Prednisone—Crohn's disease	0.00104	0.00117	CcSEcCtD
Indapamide—Arthralgia—Prednisone—Crohn's disease	0.00104	0.00117	CcSEcCtD
Indapamide—Anxiety—Prednisone—Crohn's disease	0.00103	0.00116	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00103	0.00116	CcSEcCtD
Indapamide—Discomfort—Prednisone—Crohn's disease	0.00102	0.00115	CcSEcCtD
Indapamide—Anaphylactic shock—Prednisone—Crohn's disease	0.000992	0.00112	CcSEcCtD
Indapamide—Oedema—Prednisone—Crohn's disease	0.000992	0.00112	CcSEcCtD
Indapamide—Infection—Prednisone—Crohn's disease	0.000986	0.00111	CcSEcCtD
Indapamide—Shock—Prednisone—Crohn's disease	0.000976	0.0011	CcSEcCtD
Indapamide—Nervous system disorder—Prednisone—Crohn's disease	0.000973	0.0011	CcSEcCtD
Indapamide—Tachycardia—Prednisone—Crohn's disease	0.000969	0.00109	CcSEcCtD
Indapamide—Skin disorder—Prednisone—Crohn's disease	0.000964	0.00108	CcSEcCtD
Indapamide—Hyperhidrosis—Prednisone—Crohn's disease	0.000959	0.00108	CcSEcCtD
Indapamide—Anorexia—Prednisone—Crohn's disease	0.000946	0.00106	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000904	0.00102	CcSEcCtD
Indapamide—Insomnia—Prednisone—Crohn's disease	0.000898	0.00101	CcSEcCtD
Indapamide—Paraesthesia—Prednisone—Crohn's disease	0.000891	0.001	CcSEcCtD
Indapamide—Dyspepsia—Prednisone—Crohn's disease	0.000874	0.000983	CcSEcCtD
Indapamide—Decreased appetite—Prednisone—Crohn's disease	0.000863	0.000971	CcSEcCtD
Indapamide—Fatigue—Prednisone—Crohn's disease	0.000856	0.000963	CcSEcCtD
Indapamide—Constipation—Prednisone—Crohn's disease	0.000849	0.000955	CcSEcCtD
Indapamide—Feeling abnormal—Prednisone—Crohn's disease	0.000818	0.00092	CcSEcCtD
Indapamide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000811	0.000913	CcSEcCtD
Indapamide—Urticaria—Prednisone—Crohn's disease	0.000788	0.000887	CcSEcCtD
Indapamide—Abdominal pain—Prednisone—Crohn's disease	0.000784	0.000883	CcSEcCtD
Indapamide—Body temperature increased—Prednisone—Crohn's disease	0.000784	0.000883	CcSEcCtD
Indapamide—Hypersensitivity—Prednisone—Crohn's disease	0.000731	0.000823	CcSEcCtD
Indapamide—Asthenia—Prednisone—Crohn's disease	0.000712	0.000801	CcSEcCtD
Indapamide—Pruritus—Prednisone—Crohn's disease	0.000702	0.00079	CcSEcCtD
Indapamide—Diarrhoea—Prednisone—Crohn's disease	0.000679	0.000764	CcSEcCtD
Indapamide—Dizziness—Prednisone—Crohn's disease	0.000656	0.000739	CcSEcCtD
Indapamide—Vomiting—Prednisone—Crohn's disease	0.000631	0.00071	CcSEcCtD
Indapamide—Rash—Prednisone—Crohn's disease	0.000626	0.000704	CcSEcCtD
Indapamide—Dermatitis—Prednisone—Crohn's disease	0.000625	0.000704	CcSEcCtD
Indapamide—Headache—Prednisone—Crohn's disease	0.000622	0.0007	CcSEcCtD
Indapamide—Nausea—Prednisone—Crohn's disease	0.000589	0.000663	CcSEcCtD
